Assessing immune responses to pneumococcal vaccines [8]

Archives of Disease in Childhood

Volumn 88, Issue 7, 2003, Pages 648-649

  Lakshman, R ^a,c   Gennery, A R ^a   Arkwright, P D ^a   Flood, T ^a   Abinun, M ^a   Spickett, G ^a   Borrows, R ^a   Cant, A J ^a   Balmer, P ^b   Borrow, R ^b  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c SHEFFIELD CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; PNEUMOCOCCUS VACCINE; BACTERIUM ANTIBODY; VACCINE;

ANTIBODY RESPONSE; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; IMMUNOGENICITY; LETTER; PRIORITY JOURNAL; RECURRENT INFECTION; BIOSYNTHESIS; CHILD; IMMUNOLOGY; NOTE; PRESCHOOL CHILD; STREPTOCOCCUS PNEUMONIAE;

ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; HUMANS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

EID: 17944384903     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.7.648     Document Type: Letter

References (5)

1. Finn A, Booy R, Sharland M, et al. Should the new pneumococcal vaccine be used in high-risk children? Arch Dis Child 2002;87:18-21.
2. Finn A, Booy R, Sharland M, et al. Conflicting advice. Arch Dis Child 2003;88:176.
3. Rijkers GT, Sandesr LAM, Zegers BJM. Anti-capsular polysaccharide antibody deficiency states. Immunodeficieny 1993;5:1-21.
4. Griffiths H, Lea J, Bunch C, et al. Predictors of infection in chronic lymphocytic leukaemia (CLL). Clin Exp Immunol 1992;89:374-7.
5. Luis Jódar, Jay Butler, George Carlone, et al. Serological criteria for evaluation and licensure of new pneumococcal conjugate vaccine formulations for use in infants. Vaccine 2003 [in press].